Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_assertion type Assertion NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_head.
- NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_assertion description "[This study examined whether the therapeutic efficacy of benazepril on essential hypertension is modified by beta2 adrenergic receptor gene (ADRB2) Arg16Gly (R16G) polymorphism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_provenance.
- NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_assertion evidence source_evidence_literature NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_provenance.
- NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_assertion SIO_000772 15554460 NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_provenance.
- NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_assertion wasDerivedFrom befree-2016 NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_provenance.
- NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_assertion wasGeneratedBy ECO_0000203 NP469704.RAOkMA2wVa4CkvsgGJdDjjIofft9oE1fjKiVPgZAZjvzE130_provenance.